RNA Formulation Solutions
-
GenVoy-ILM™ T-Cell Kits For mRNA
4/24/2025
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
Delivering Best-In-Class Nanoparticles
6/30/2025
Achieve uniformity and control in nanoparticle synthesis with an advanced system that streamlines production, reduces human intervention, and delivers exceptional particle characteristics for diverse applications.
-
in vivo-jetRNA®+
9/14/2022
Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry. -
Accelerate Development With Large-Scale mRNA And LNP Production
10/16/2024
Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.
-
Cleanrooms And Equipment For mRNA Drug Manufacturing
6/9/2023
Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success
Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.
-
Pre-GMP mRNA And LNP Development
11/26/2024
Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.
-
Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles
Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
The Power Of One: mRNA Services
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
pDNA Lipid Nanoparticle Formulation And Screening Using Nova IJM
1/24/2024
Explore a platform designed to evaluate the effects of formulation and process parameters on the characteristics of DNA+LNP nanoparticles.